Tanya Gaines
Medical · San Antonio, TXNPI 1699174722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 680 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 680 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Galderma Laboratories, L.p.$1K
- Johnson & Johnson$842
- Regeneron Healthcare Solutions, Inc.$809
- Dermavant Sciences, Inc.$772
- Novartis$687
- plus $6K from 27 others
What the payments were for
- Food & beverage$13,10696%
- Education$5654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 144 | $3,152 |
| Galderma Laboratories, L.p. | 48 | $1,390 |
| Johnson & Johnson | 32 | $842 |
| Regeneron Healthcare Solutions, Inc. | 58 | $809 |
| Dermavant Sciences, Inc. | 47 | $772 |
| Novartis | 53 | $687 |
| Pfizer | 52 | $665 |
| Incyte Corporation | 35 | $655 |
| E.r. Squibb & Sons, L.L.C. | 30 | $635 |
| Lilly USA, LLC | 25 | $622 |
| UCB, Inc. | 23 | $618 |
| Arcutis Biotherapeutics, Inc. | 18 | $350 |
| Sun Pharmaceutical Industries Inc. | 20 | $339 |
| Sanofi | 13 | $267 |
| LEO Pharma Inc. | 15 | $257 |
| Krystal Biotech Inc | 6 | $249 |
| Amgen | 6 | $168 |
| Boehringer Ingelheim | 7 | $156 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $143 |
| Nobelpharma America, LLC | 1 | $140 |
| Revance Therapeutics, Inc. | 1 | $130 |
| Organon | 10 | $117 |
| Biofrontera Inc. | 6 | $107 |
| Kerecis Limited | 5 | $86 |
| Genentech USA, Inc. | 4 | $80 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Botanix SB Inc | 2 | $38 |
| VYNE Pharmaceuticals Inc. | 2 | $32 |
| Verrica Pharmaceuticals Inc. | 2 | $29 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $25 |
| Octapharma USA, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,670 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 16 | $70,415 |
| Clobetasol Propionate | 15 | $803 |
| Ketoconazole | 44 | $407 |
| Triamcinolone Acetonide | 22 | $396 |
| Clindamycin Phosphate | 15 | $356 |
| Ciclopirox | 13 | $256 |
| Mupirocin | 17 | $160 |
Paid to pharmacies, not to this prescriber.
Other medical in San Antonio
- Shakira CabreraSan Antonio$116K
- Courtney AldridgeSan Antonio$89K
- John KodoskySan Antonio$58K
- Amanda MillerSan Antonio$27K
- Felipe GalvanSan Antonio$26K
- Ledyenska BallesterosSan Antonio$22K
- Daniella ArellanoSan Antonio$15K
- Robert SchonhoffSan Antonio$14K
- Ivanna SaucedoSan Antonio$13K
- Mui LeeSan Antonio$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.